Skip to main content
. 2019 Feb 16;110(3):1117–1126. doi: 10.1111/cas.13955

Figure 4.

Figure 4

Kaplan‐Meier survival analyses and SPATA2 expression in ovarian cancer (OC) patients. Progression‐free survival according to low and high SPATA2 mRNA expression in (A) OC patients (n = 170) and (B) the subgroup of patients with HGSOC (n = 61). Overall survival according to low and high SPATA2 mRNA expression in (C) OC patients (n = 170) and (D) the subgroup of patients with HGSOC (n = 61)